Agazie YM - Search Results

1

Regulation of anti-apoptotic signaling by Kruppel-like factors 4 and 5 mediates lapatinib resistance in breast cancer.

Farrugia MK, Sharma SB, Lin CC, McLaughlin SL, Vanderbilt DB, Ammer AG, Salkeni MA, Stoilov P, Agazie YM, Creighton CJ, Ruppert JM. Farrugia MK, et al. Among authors: agazie ym. Cell Death Dis. 2015 Mar 19;6(3):e1699. doi: 10.1038/cddis.2015.65. Cell Death Dis. 2015. PMID: 25789974 Free PMC article.

2

Inhibition of SHP2 leads to mesenchymal to epithelial transition in breast cancer cells.

Zhou XD, Agazie YM. Zhou XD, et al. Among authors: agazie ym. Cell Death Differ. 2008 Jun;15(6):988-96. doi: 10.1038/cdd.2008.54. Epub 2008 Apr 18. Cell Death Differ. 2008. PMID: 18421299

3

SHP2 is up-regulated in breast cancer cells and in infiltrating ductal carcinoma of the breast, implying its involvement in breast oncogenesis.

Zhou X, Coad J, Ducatman B, Agazie YM. Zhou X, et al. Among authors: agazie ym. Histopathology. 2008 Oct;53(4):389-402. doi: 10.1111/j.1365-2559.2008.03103.x. Epub 2008 Jul 15. Histopathology. 2008. PMID: 18643929

4

SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer.

Matalkah F, Martin E, Zhao H, Agazie YM. Matalkah F, et al. Among authors: agazie ym. Breast Cancer Res. 2016 Jan 4;18(1):2. doi: 10.1186/s13058-015-0659-z. Breast Cancer Res. 2016. PMID: 26728598 Free PMC article.

5

Conditional knockout of SHP2 in ErbB2 transgenic mice or inhibition in HER2-amplified breast cancer cell lines blocks oncogene expression and tumorigenesis.

Zhao H, Martin E, Matalkah F, Shah N, Ivanov A, Ruppert JM, Lockman PR, Agazie YM. Zhao H, et al. Among authors: agazie ym. Oncogene. 2019 Mar;38(13):2275-2290. doi: 10.1038/s41388-018-0574-8. Epub 2018 Nov 22. Oncogene. 2019. PMID: 30467378 Free PMC article.

6

Molecular mechanism for SHP2 in promoting HER2-induced signaling and transformation.

Zhou X, Agazie YM. Zhou X, et al. Among authors: agazie ym. J Biol Chem. 2009 May 1;284(18):12226-34. doi: 10.1074/jbc.M900020200. Epub 2009 Mar 4. J Biol Chem. 2009. PMID: 19261604 Free PMC article.

7

The signaling and transformation potency of the overexpressed HER2 protein is dependent on the normally-expressed EGFR.

Zhou X, Agazie YM. Zhou X, et al. Among authors: agazie ym. Cell Signal. 2012 Jan;24(1):140-50. doi: 10.1016/j.cellsig.2011.08.015. Epub 2011 Sep 3. Cell Signal. 2012. PMID: 21911055 Free PMC article.

8

HER2 stabilizes EGFR and itself by altering autophosphorylation patterns in a manner that overcomes regulatory mechanisms and promotes proliferative and transformation signaling.

Hartman Z, Zhao H, Agazie YM. Hartman Z, et al. Among authors: agazie ym. Oncogene. 2013 Aug 29;32(35):4169-80. doi: 10.1038/onc.2012.418. Epub 2012 Oct 1. Oncogene. 2013. PMID: 23027125 Free PMC article.

9

Inhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatment.

Zhao H, Agazie YM. Zhao H, et al. Among authors: agazie ym. BMC Cancer. 2015 Mar 8;15:109. doi: 10.1186/s12885-015-1131-2. BMC Cancer. 2015. PMID: 25885600 Free PMC article.

10

The tyrosine phosphatase SHP2 regulates focal adhesion kinase to promote EGF-induced lamellipodia persistence and cell migration.

Hartman ZR, Schaller MD, Agazie YM. Hartman ZR, et al. Among authors: agazie ym. Mol Cancer Res. 2013 Jun;11(6):651-64. doi: 10.1158/1541-7786.MCR-12-0578. Epub 2013 Mar 19. Mol Cancer Res. 2013. PMID: 23512980 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters